$WKHS
Workhorse Group Inc. Stock $wkhs

$wkhs Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023018011 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.966M	$1.693M	$14.30K
YoY Change	31480.12%	11742.06%	-97.26%
Cost Of Revenue	$8.427M	$5.328M	$3.923M
YoY Change	179.03%	35.81%	-36.98%
Gross Profit	-$4.461M	-$3.635M	-$3.909M
YoY Change	48.32%	-7.02%	-31.47%
Gross Profit Margin	-112.47%	-214.64%	-27336.03%
Selling, General & Admin	$14.00M	$14.69M	$11.91M
YoY Change	7.46%	23.34%	72.97%
% of Gross Profit
Research & Development	$5.060M	$7.225M	$4.012M
YoY Change	0.65%	80.08%	3.84%
% of Gross Profit
Depreciation & Amortization	$746.3K	$640.4K	$320.0K
YoY Change	91.17%	100.12%	2.84%
% of Gross Profit
Operating Expenses	$19.06M	$21.91M	$15.92M
YoY Change	5.57%	37.64%	48.12%
Operating Profit	-$23.52M	-$25.55M	-$19.83M
YoY Change	11.67%	28.83%	20.53%
Interest Expense	$505.5K	$550.4K	-$700.1K
YoY Change		-178.61%	-105.19%
% of Operating Profit
Other Income/Expense, Net			-$1.523M
YoY Change			-98.88%
Pretax Income	-$23.02M	-$25.00M	-$22.05M
YoY Change	8.78%	13.35%	-84.03%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$23.02M	-$25.00M	-$22.05M
YoY Change	8.78%	13.36%	-81.7%
Net Earnings / Revenue	-580.31%	-1476.31%	-154227.52%
Basic Earnings Per Share	-$0.12	-$0.15	-$0.15
Diluted Earnings Per Share	-$0.12	-$0.15	-$0.15
COMMON SHARES
Basic Shares Outstanding	185.0M shares	171.2M shares	151.9M shares
Diluted Shares Outstanding	185.7M shares	167.1M shares	151.9M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.38M	$79.11M	$167.0M
YoY Change	-55.46%	-52.64%	-58.13%
Cash & Equivalents	$62.40M	$79.10M	$167.0M
Short-Term Investments
Other Short-Term Assets	$827.5K	$718.8K	$487.5K
YoY Change	60.87%	47.45%	-98.67%
Inventory	$34.62M	$21.94M	$12.68M
Prepaid Expenses
Receivables	$2.837M	$1.815M	$51.43K
Other Receivables	$15.00M	$15.00M	$0.00
Total Short-Term Assets	$124.3M	$132.8M	$188.6M
YoY Change	-24.74%	-29.58%	-59.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.30M	$26.92M	$10.74M
YoY Change	130.44%	150.74%	-13.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$10.00M	$10.00M
YoY Change
Other Assets	$176.3K	$176.3K	$126.3K
YoY Change	39.59%	39.59%
Total Long-Term Assets	$52.64M	$48.54M	$20.88M
YoY Change	107.43%	132.48%	69.02%
TOTAL ASSETS
Total Short-Term Assets	$124.3M	$132.8M	$188.6M
Total Long-Term Assets	$52.64M	$48.54M	$20.88M
Total Assets	$176.9M	$181.4M	$209.5M
YoY Change	-7.14%	-13.43%	-56.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.23M	$14.46M	$6.259M
YoY Change	170.09%	131.02%	-1.8%
Accrued Expenses	$43.05M	$45.04M	$9.946M
YoY Change	348.61%	352.82%	67.94%
Deferred Revenue	$1.406M	$2.207M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$58.09M	$65.16M	$21.50M
YoY Change	227.17%	203.13%	22.48%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$25.07M
YoY Change		-100.0%	-86.24%
Other Long-Term Liabilities	$11.44M	$11.40M	$6.764M
YoY Change	27.98%	68.61%	3166.87%
Total Long-Term Liabilities	$11.44M	$11.40M	$31.84M
YoY Change	27.98%	-64.18%	15276.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.09M	$65.16M	$21.50M
Total Long-Term Liabilities	$11.44M	$11.40M	$31.84M
Total Liabilities	$69.54M	$76.56M	$53.33M
YoY Change	160.46%	43.56%	-73.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$675.7M	-$652.6M	-$532.4M
YoY Change	22.06%	22.57%	131.96%
Common Stock	$205.2K	$180.6K	$152.0K
YoY Change	28.22%	18.81%	23.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$107.4M	$104.8M	$156.2M
YoY Change
Total Liabilities & Shareholders Equity	$176.9M	$181.4M	$209.5M
YoY Change	-7.14%	-13.43%	-56.33%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$23.02M	-$25.00M	-$22.05M
YoY Change	8.78%	13.36%	-81.7%
Depreciation, Depletion And Amortization	$746.3K	$640.4K	$320.0K
YoY Change	91.17%	100.12%	2.84%
Cash From Operating Activities	-$33.05M	-$32.70M	-$30.74M
YoY Change	33.7%	6.37%	-11.92%
INVESTING ACTIVITIES
Capital Expenditures	$5.068M	$5.405M	$3.596M
YoY Change	-345.67%	50.3%	184.31%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.068M	-$5.405M	-$3.596M
YoY Change	145.67%	50.3%	184.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.39M	$17.99M	-$261.2K
YoY Change	-10565.28%	-6986.94%	-1936.82%
NET CHANGE
Cash From Operating Activities	-33.05M	-$32.70M	-$30.74M
Cash From Investing Activities	-5.068M	-$5.405M	-$3.596M
Cash From Financing Activities	21.39M	$17.99M	-$261.2K
Net Change In Cash	-16.73M	-$20.17M	-$34.60M
YoY Change	-38.0%	-41.72%	-4.3%
FREE CASH FLOW
Cash From Operating Activities	-$33.05M	-$32.70M	-$30.74M
Capital Expenditures	$5.068M	$5.405M	$3.596M
Free Cash Flow	-$38.12M	-$38.10M	-$34.34M
YoY Change	68.24%	10.97%	-5.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001425287
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37673
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	WORKHORSE GROUP INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1394771
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3600 Park 42 Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 160E
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Sharonville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45241
CY2023Q1	dei	City Area Code CityAreaCode	888
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	646-5205
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	WKHS
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	184958342	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79110576	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99276301	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	46259	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1815320	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2079343	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15000000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15000000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	21937725	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8850142	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14984887	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14152481	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	132848508	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	139358267	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26924853	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21501095	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	10000000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	10000000	usd
CY2023Q1	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11434325	usd
CY2022Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11706803	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176310	usd
CY2023Q1	us-gaap	Assets Assets	181383996	usd
CY2022Q4	us-gaap	Assets Assets	182742475	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14458894	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10235345	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45035950	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46207431	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2207250	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3375000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2066588	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2207674	usd
CY2023Q1	wkhs	Lease Liability Current LeaseLiabilityCurrent	1390135	usd
CY2022Q4	wkhs	Lease Liability Current LeaseLiabilityCurrent	1285032	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	65158817	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63310482	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2940749	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2005000	usd
CY2023Q1	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8463882	usd
CY2022Q4	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8840062	usd
CY2023Q1	us-gaap	Liabilities Liabilities	76563448	usd
CY2022Q4	us-gaap	Liabilities Liabilities	74155544	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	180580804	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	180580804	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	165605355	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	165605355	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	180580	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	165605	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	757288067	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	736070388	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-652648099	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-627649062	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	104820548	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	181383996	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	182742475	usd
CY2023Q1	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	1693415	usd
CY2022Q1	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	14299	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	5328119	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3923351	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-3634704	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-3909052	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14689843	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11910259	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7224849	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4011934	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	21914692	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	15922193	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-25549396	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19831245	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	550359	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2223290	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24999037	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22054535	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24999037	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-22054535	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167144351	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	167144351	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151939491	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151939491	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	108586931	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18592188	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-383923	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3024389	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24999037	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	104820548	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	174692773	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-196262	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2350293	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-22054535	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1402500	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	156194769	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24999037	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-22054535	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	640362	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	319984	usd
CY2023Q1	wkhs	Change In Fair Value And Loss On Exchange Convertible Notes ChangeInFairValueAndLossOnExchangeConvertibleNotes	0	usd
CY2022Q1	wkhs	Change In Fair Value And Loss On Exchange Convertible Notes ChangeInFairValueAndLossOnExchangeConvertibleNotes	-1769857	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-232001	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3024389	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2350293	usd
CY2023Q1	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-149496	usd
CY2022Q1	wkhs	Change In Inventory And Prepaid Purchases Reserve ChangeInInventoryAndPrepaidPurchasesReserve	-519939	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-221262	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-310480	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-120273	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-98347	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13320359	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3477474	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	749125	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4166915	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	55661	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2536424	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6088342	usd
CY2023Q1	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-141086	usd
CY2022Q1	wkhs	Increase Decrease In Extended Warranty Liability IncreaseDecreaseInExtendedWarrantyLiability	-268453	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32749402	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-30742480	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5404727	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3595842	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5404727	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3595842	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18592188	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	219861	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	64934	usd
CY2023Q1	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-383923	usd
CY2022Q1	wkhs	Exercise Of Warrants And Options And Restricted Share Award Activity ExerciseOfWarrantsAndOptionsAndRestrictedShareAwardActivity	-196262	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17988404	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-261196	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20165725	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34599518	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99276301	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	201647394	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79110576	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167047876	usd
CY2023Q1	wkhs	Revenue From Contract With Customer Excluding Assessed Tax Net Of Returns And Allowances RevenueFromContractWithCustomerExcludingAssessedTaxNetOfReturnsAndAllowances	1700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32700000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79100000	usd
CY2023Q1	wkhs	Working Capital WorkingCapital	67700000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-652600000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	42500878	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	103444	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	25210131	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period balances have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and the accompanying notes. These reclassifications have no effect on previously reported results of operations or stockholders’ equity.</span></div>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes.</span></div>
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	19600931	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4891142	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	301645	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	24595517	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	68012654	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2657792	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	59162512	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	21937725	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	8850142	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2700000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	59200000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	35143035	usd
CY2022Q4	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	34611649	usd
CY2023Q1	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	22080204	usd
CY2022Q4	us-gaap	Contract With Customer Asset Accumulated Allowance For Credit Loss Current ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent	22163338	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	13062831	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	12448311	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1203243	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1198769	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	718813	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	505401	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14984887	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14152481	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1693415	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14299	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5100000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5400000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2200000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	35000000	usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	35000000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4714720	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4967187	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5321230	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6240244	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45035950	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	46207431	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4583916	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	287813	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	987701	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	146727	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-1388541	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2066588	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2207674	usd
CY2023Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	58307	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	175905	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	572340	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	297423	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	630647	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	473328	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5662577	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5884865	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5771748	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5821938	usd
CY2023Q1	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11434325	usd
CY2022Q4	wkhs	Lease Right Of Use Assets LeaseRightOfUseAssets	11706803	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	6851027	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6977896	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3002990	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3147198	usd
CY2023Q1	wkhs	Lease Liability LeaseLiability	9854017	usd
CY2022Q4	wkhs	Lease Liability LeaseLiability	10125094	usd
CY2023Q1	wkhs	Lease Liability Current LeaseLiabilityCurrent	1390135	usd
CY2022Q4	wkhs	Lease Liability Current LeaseLiabilityCurrent	1285032	usd
CY2023Q1	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8463882	usd
CY2022Q4	wkhs	Lease Liability Noncurrent LeaseLiabilityNoncurrent	8840062	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	13000000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	8800	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3024389	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2350293	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	423626	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.60
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	200	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.81
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	423426	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.63
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	271210	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.29
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y4M24D
CY2022Q1	wkhs	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	175000000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	14400000	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	18600000	usd
CY2023Q1	wkhs	Sale Of Stock Remaining Authorized Amount SaleOfStockRemainingAuthorizedAmount	142900000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd

Files In Submission

Name	View Source	Status
0001628280-23-018011-index-headers.html	Edgar Link	pending
0001628280-23-018011-index.html	Edgar Link	pending
0001628280-23-018011.txt	Edgar Link	pending
0001628280-23-018011-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20230331.htm	Edgar Link	pending
wkhs-20230331.xsd	Edgar Link	pending
wkhs-20230331xexx311.htm	Edgar Link	pending
wkhs-20230331xexx312.htm	Edgar Link	pending
wkhs-20230331xexx321.htm	Edgar Link	pending
wkhs-20230331xexx322.htm	Edgar Link	pending
workhorse2023long-termince.htm	Edgar Link	pending
wkhs-20230331_lab.xml	Edgar Link	unprocessable
wkhs-20230331_pre.xml	Edgar Link	unprocessable
wkhs-20230331_cal.xml	Edgar Link	unprocessable
wkhs-20230331_def.xml	Edgar Link	unprocessable
wkhs-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKHS
Workhorse Group Inc. Stock $wkhs

2023 Q2 Form 10-Q Financial Statement

#000162828023018011 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS Workhorse Group Inc. Stock $wkhs

2023 Q2 Form 10-Q Financial Statement

#000162828023018011 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS
Workhorse Group Inc. Stock $wkhs